Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Merceditas S. Villanueva"'
Publikováno v:
F1000Research, Vol 6 (2018)
Background: With the availability of direct acting antiviral treatment for hepatitis C (HCV), HIV and HCV co-infected patients show comparable treatment responses to HCV-monoinfected patients. An 8-week course of sofosbuvir/ledipasvir (SOF/LDV) is hi
Externí odkaz:
https://doaj.org/article/805a154e230042ae872ba033388d8c3f
Publikováno v:
BMJ case reports. 15(3)
An immunocompetent man presented with
Autor:
Michael D Virata, Sheela V Shenoi, Joseph Ladines-Lim, Merceditas S Villanueva, Lydia A Barakat
Publikováno v:
PLoS ONE, Vol 16, Iss 12, p e0260251 (2021)
There continue to be conflicting data regarding the outcomes of people with HIV (PWH) who have COVID-19 infection with most studies describing the early epidemic. We present a single site experience spanning a later timeframe from the first report on
Externí odkaz:
https://doaj.org/article/02d85ed54011446dbc156bd0a482f9d5
Autor:
Katarzyna M. Sims, Ralph Brooks, Lisa Nichols, Maximilian D. Wegener, Merceditas S. Villanueva
This chapter considers social constructivism as an educational theory for the development of multimedia content to assist primary-care providers, particularly those in HIV clinics and other clinicians, and support staff involved in the care of patien
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1eac314032a9827ee298cb5e9e0f7546
https://doi.org/10.4018/978-1-7998-9490-2.ch010
https://doi.org/10.4018/978-1-7998-9490-2.ch010
Publikováno v:
BMJ Case Reports. 15:e247495
An immunocompetent man presented withCryptococcus neoformansdisease manifesting as a large pulmonary mass (cryptococcoma). Despite an initial induction course of 4 weeks of liposomal amphotericin B (LAmB), followed by 8 weeks of fluconazole, the cryp
Autor:
Mario Javier DeLuca, Mary J.K. Kim, Wesley Kozinn, Donna Winborne, Chatrchai Watanakunakorn, Barbara Bor, Steve Parenteau, Stephen B. Kritchevsky, Christopher J. Sullivan, Barbara Russell, Kenji Kono, Jérôme Robert, Chik Hyun Pai, Didier Pittet, Marjeta Skerl, Pam Falk, Edward T. M. Smyth, Antoni Trilla, Edward S. Wong, Kelley Melton, Sue Barnett, Robert Grisnak, Jane Lane, Gwen Cunningham, Brian Koll, Jean Maurice, Peg Janasie, Stefan Weber, Joan Kies, Lynn Steele, Mary Dahlmann, Mary Kundus, Linda Matrician, Kathryn Zink, Paul M. Newell, Malkanthie I. McCormick, Christine Filippone, Janine Chapman, Bonnie Viergutz, Bonnie Greene, Jeffrey P. Engel, Terri Bethea, Debra Runyan, Jacqueline Berry, Ann Schlimm, Juan Menares, Diane Baranowsky, Clifford McDonald, Carol Jarvis, James W. Lederer, Prity L. Vaidya, Elizabeth DeHaan, Leonard A. Mermel, Michael F. Parry, Ziad A. Memish, Crésio R. Pereira, Richard J. Duma, Martin Topiel, Sharon F. Welbel, Diann Boyette, Alice Stankus, Mary F. Wisniewski, Steve L. Solomon, Jacqueline P. Butler, Gregory Bond, G. Merrill Shore, Catherine O'Neill, Joseph R. Thurn, Ruth Carrico, Sandi Baus, Barbara I. Braun, W. Lee Fanning, Brenda Grant, Jacquelyn Seibert, Carol Ward, Carlo Marena, Gerry McIlvenny, Cheryl L. Richards, Stuart Johnson, Robert L. Pinsky, Francis J. G. Liu, Najwa Khuri-Bulos, Bryan P. Simmons, Merceditas S. Villanueva, Le Ann Ellingson, Claudia Vallone Silva, Connie Steed
Publikováno v:
Infection Control & Hospital Epidemiology. 24:926-935
Objectives:To describe the conceptual framework and methodology of the Evaluation of Processes and Indicators in Infection Control (EPIC) study and present results of CVC insertion characteristics and organizational practices for preventing BSIs. The